Back to profiles

Carolien Maas

PhD Candidate
Carolien Maas

Research group

Medical Decision-making
Carolien Maas

Carolien Maas, MSc, recently started working on her PhD at Erasmus Medical Center (EMC) and the Netherlands Comprehensive Cancer Organization (IKNL). Her research focuses on the prognosis and optimal treatment of cancer patients. Currently, she concentrates on the estimation of the life expectancy for patients with several different types of cancer. Furthermore, she collaborates to evaluate hospital differences in treatment and survival outcomes of cancer patients in the Netherlands.

Her background in Econometrics allows her to have a data-driven perspective. During her Econometrics bachelor degree at the University of Amsterdam (UvA), she broadened her knowledge by taking courses on Programming and Artificial Intelligence.

Her master degree in Business Analytics and Quantitative Marketing at Erasmus University (EUR) provided her with many data science techniques that are frequently useful in practice. The topic of her master thesis was ‘Evaluating heterogeneous treatment effect estimation in randomized clinical trials’. She evaluated several performance metrics to evaluate mathematical models designed to estimate individualized treatment effect and will publish a paper about this soon. This way, she aims to contribute to data-driven solutions to provide treatment plans tailored to fit each individual patient.

CV Curriculum Vitae

Erasmus Medical Center Rotterdam
Internal post address Na-2401
P.O. Box 2040
3000 CA Rotterdam

Visitor address:

Erasmus MC
Dr. Molewaterplein 40
3015 GD Rotterdam

Prognosis and optimal treatment of cancer patients.

  • Advanced Analysis of Prognosis Studies (https://www.nihes.com/course/el014_advanced_analysis_of_prognosis_studies/)
  • Consultant for the Master Consultancy Program
  • Community projects for bachelor medical students

Committee member of

Publications list

Most relevant publications

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989–2018

Carolien C. H. M. Maas, David van Klaveren, Geneviève I. C. G. Ector, Eduardus F. M. Posthuma, Otto Visser, Peter E. Westerweel, Jeroen J. W. M. Janssen, Nicole M. A. Blijlevens, Avinash G. Dinmohamed

British Journal of Hematology

Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018

Lina van der Straten, Carolien C. H. M. Maas, Mark-David Levin, Otto Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, Anton W. Langerak, Arnon P. Kater & Avinash G. Dinmohamed

Blood Cancer Journal

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A W Dinnessen 1 2 , Carolien C H M Maas 3 4 , Sanne H Tonino 5 , Otto Visser 6 , Eduardus F M Posthuma 7 8 , Nicole M A Blijlevens 9 , Marie José Kersten 5 , Pieternella J Lugtenburg 10 , Avinash G Dinmohamed 3 5 4 11

Leukemia

Programming languages

  • R
  • Python
  • Stata

NIHES courses

  • Principles of Research in Medicine (ESP01)
  • Joint Models Longitudinal Survival Data (ESP27)
  • Study Design (CK010)
  • Topics in Medical Decision Making (EL004)

Near-normal life expectancy for patients with chronic myeloid leukemia

The loss of life expectancy in patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2018